<DOC>
	<DOCNO>NCT00220116</DOCNO>
	<brief_summary>To assess efficacy safety combination capecitabine oxaliplatin 1st , 2nd subsequent line treatment metastatic colorectal cancer , also neo-adjuvant adjuvant set resectable metastasis . Primary Endpoint : Objective response rate Secondary Endpoints : Treatment related toxicity Progression free survival ( If resect ) Disease free Survival ( From metastastectomy , resect ) Overall Survival 60 Day cause mortality Number undergoing liver resections/curative resection ( Ro ) rate</brief_summary>
	<brief_title>Phase II Trial Assessing Efficacy Toxicity Capecitabine Oxaliplatin Treatment Colorectal Cancer</brief_title>
	<detailed_description />
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>Age &gt; 18 Histologically proven colorectal adenocarcinoma , require therapy define one four treatment subgroup No previous malignant disease nonmelanotic skin cancer carcinomainsitu uterine cervix . Unidimensional measurable disease assess CT. ( Unless adjuvant therapy ) Adequate bone marrow function ; Hb &gt; 10g/dl , platelet &gt; 100 x109/l , WBC &gt; 3x109/l , Neut &gt; 1.5x109/l . Adequate liver function : Serum Bilirubin &lt; 1.5 x upper limit institutional normal Adequate renal function , calculate Creatinine Clearance &gt; 50mls/min No concurrent uncontrolled medical condition WHO performance status 0,1 2 Adequate contraceptive precaution , appropriate Informed write consent Negative pregnancy test woman child bear age Life expectancy &gt; 3 month Medical psychiatric condition comprise patient 's ability take inform consent . Clinically significant ( i.e . active ) cardiac disease ( e.g . congestive heart failure , symptomatic coronary artery disease cardiac arrhythmia even control medication ) myocardial infarction within last 12 month . Patients significant symptoms history peripheral neuropathy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>